SEARCH

SEARCH BY CITATION

References

  • Asai M., Hattori C., Iwata N., et al. (2006) The novel β-secretase inhibitor KMI-429 reduces amyloid β peptide production in amyloid precursor protein transgenic and wild type mice. J. Neurochem. 96, 533540.
  • Cai H., Wang Y., McCarthy D., Wen H., Borchelt D. R., Price D. L. and Wong P. C. (2001) BACE1 is the major β-secretase for generation of Aβ peptides by neurons. Nat. Neurosci. 4, 233234.
  • Chang W.-P., Koelsch G., Wong S. et al. (2004) In vivo inhibition of Aβ production by memapsin 2 (β-secretase) inhibitors. J. Neurochem. 89, 14091416.
  • Charlwood J., Dingwall C., Matico R., et al. (2001) Characterization of the glycosylation profiles of Alzheimer's β-secretase protein Asp-2 expressed in a variety of cell lines. J. Biol. Chem. 276, 16 73916 748.
  • Cordy J. M., Hussain I., Dingwall C., Hooper N. M. and Turner A. J. (2003) Exclusively targeting β-secretase to lipid rafts by GPI-anchor addition up-regulates β-site processing of the amyloid precursor protein. Proc. Natl. Acad. Sci. U.S.A. 100, 11 73511 740.
  • Demeule M., Regina A., Jodoin J., Laplante A., Dagenais C., Berthelet F., Moghrabi A. and Beliveau R. (2002) Drug transport to the brain: key roles for the efflux pump P-glycoprotein in the blood–brain barrier. Vascul. Pharmacol. 38, 339348.
  • Fukumoto H., Cheung B. S., Hyman B. T. and Irizarry M. C. (2002) β-secretase protein and activity are increased in the neocortex in Alzheimer disease. Arch. Neurol. 59, 13811389.
  • Glenner G. G. and Wong C. W. (1984) Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun. 120, 885890.
  • Goedert M., Wischik C. M., Crowther R. A., Walker J. E. and Klug A. (1988) Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer disease: identification as the microtubule-associated protein tau. Proc. Natl. Acad. Sci. U.S.A. 85, 40514055.
  • Gruninger-Leitch F., Schlatter D., Kung E., Nelbock P. and Dobeli H. (2002) Substrate and inhibitor profile of BACE (β-secretase) and comparison with other mammalian aspartic proteases. J. Biol. Chem. 277, 46874693.
  • Hanessian S., Yun H., Hou Y., et al. (2005) Structure-based design, synthesis, and memapsin 2 (BACE) inhibitory activity of carbocyclic and heterocyclic peptidomimetics. J. Med. Chem. 48, 51755190.
  • Hong L., Koelsch G., Lin X., Wu S., Terzyan S., Ghosh A. K., Zhang X. C. and Tang J. (2000) Structure of the protease domain of memapsin 2 (β-secretase) complexed with inhibitor. Science 290, 150153.
  • Howlett D. R., Richardson J. C., Austin A., Parsons A. A., Bate S. T., Davies D. C. and Gonzalez M. I. (2004) Cognitive correlates of Aβ deposition in male and female mice bearing amyloid precursor protein and presenilin-1 mutant transgenes. Brain Res. 1017, 130136.
  • Hussain I. (2004) The potential for BACE1 inhibitors in the treatment of Alzheimer's disease. Idrugs 7, 653658.
  • Hussain I., Powell D., Howlett D. R., et al. (1999) Identification of a Novel Aspartic Protease (Asp2) as β-secretase. Mol. Cell. Neurosci. 14, 419427.
  • Hussain I., Powell D. J., Howlett D. R., et al. (2000) ASP1 (BACE2) cleaves the amyloid precursor protein at the β-secretase site. Mol. Cell. Neurosci. 16, 609619.
  • Hyafil F., Vergely C., Du Vignaud P. and Grand-Perret T. (1993) In vitro and in vivo reversal of multidrug resistance by GF120918, an acridonecarboxamide derivative. Cancer Res. 53, 45954602.
  • John V. (2006) Human β-secretase (BACE) and BACE inhibitors: Progress Report. Curr. Top. Med. Chem. 6, 569578.
  • Kimura T., Shuto D., Hamada Y., et al. (2005) Design and synthesis of highly active Alzheimer's β-secretase (BACE1) inhibitors, KMI-420 and KMI-429, with enhanced chemical stability. Bioorg. Med. Chem. Lett. 15, 211215.
  • Li R., Lindholm K., Yang L. B., et al. (2004) Amyloid β peptide load is correlated with increased β-secretase activity in sporadic Alzheimer's disease patients. Proc. Natl. Acad. Sci. U.S.A. 101, 36323637.
  • Lin X., Koelsch G., Wu S., Downs D., Dashti A. and Tang J. (2000) Human aspartic protease memapsin 2 cleaves the β-secretase site of β-amyloid precursor protein. Proc. Natl. Acad. Sci. U.S.A. 97, 14561460.
  • Luo Y., Bolon B., Kahn S., et al. (2001) Mice deficient in BACE1, the Alzheimer's β-secretase, have normal phenotype and abolished β-amyloid generation. Nat. Neurosci. 4, 231232.
  • Mattson M. P., Cheng B., Culwell A. R., Esch F. S., Lieberburg I. and Rydel R. E. (1993) Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of the β-amyloid precursor protein. Neuron 10, 243254.
  • Mosmann T. (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65, 5563.
  • Ohno M., Sametsky E. A., Younkin L. H., Oakley H., Younkin S. G., Citron M., Vassar R. and Disterhoft J. F. (2004) BACE1 deficiency rescues memory deficits and cholinergic dysfunction in a mouse model of Alzheimer's disease. Neuron 41, 2733.
  • Polli J. W., Jarrett J. L., Studenberg S. D., Humphreys J. E., Dennis S. W., Brouwer K. R. and Woolley J. L. (1999) Role of P-glycoprotein on the CNS disposition of amprenavir (141W94), an HIV protease inhibitor. Pharm. Res. 16, 12061212.
  • Roberds S. L., Anderson J., Basi G., et al. (2001) BACE knockout mice are healthy despite lacking the primary β-secretase activity in brain: implications for Alzheimer's disease therapeutics. Hum. Mol. Genet. 10, 13171324.
  • Selkoe D. J. (1994) Cell biology of the amyloid β-protein precursor and the mechanism of Alzheimer's disease. Annu. Rev. Cell. Biol. 10, 373403.
  • Sinha S., Anderson J. P., Barbour R., et al. (1999) Purification and cloning of amyloid precursor protein β-secretase from human brain. Nature 402, 537540.
  • Stachel S. J., Coburn C. A., Steele T. G., et al. (2004) Structure-based design of potent and selective cell-permeable inhibitors of human β-secretase (BACE-1). J. Med. Chem. 47, 64476450.
  • Stachel S. J., Coburn C. A., Steele T. G., et al. (2006) Conformationally biased P3 amide replacements of β-secretase inhibitors. Bioorg. Med. Chem. Lett. 16, 641644.
  • Vassar R., Bennett B. D., Babu-Khan S., et al. (1999) β-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science 286, 735741.
  • Wang G. T., Chung C. C., Holzman T. F. and Krafft G. A. (1993) A continuous fluorescence assay of renin activity. Anal. Biochem. 210, 351359.
  • Yan R., Bienkowski M. J., Shuck M. E., et al. (1999) Membrane-anchored aspartyl protease with Alzheimer's disease β-secretase activity. Nature 402, 533537.
  • Yang L., Lindholm K., Yan R., et al. (2003) Elevated β-secretase expression and enzymatic activity detected in sporadic Alzheimer disease. Nat. Med. 9, 34.
  • Yang W., Lu W., Lu Y., et al. (2006) Aminoethylenes: a tetrahedral intermediate isostere yielding potent inhibitors of the aspartyl protease BACE-1. J. Med. Chem. 49, 839842.
  • Ziora Z., Kimura T. and Kiso Y. (2006) Small-sized BACE1 inhibitors. Drugs Future 31, 5363.